SE9702563D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- SE9702563D0 SE9702563D0 SE9702563A SE9702563A SE9702563D0 SE 9702563 D0 SE9702563 D0 SE 9702563D0 SE 9702563 A SE9702563 A SE 9702563A SE 9702563 A SE9702563 A SE 9702563A SE 9702563 D0 SE9702563 D0 SE 9702563D0
- Authority
- SE
- Sweden
- Prior art keywords
- pct
- compounds
- sec
- date
- date oct
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- OKGNMRKOGWTADH-UHFFFAOYSA-N 1,4-dihydropyrimidine Chemical compound C1C=CNC=N1 OKGNMRKOGWTADH-UHFFFAOYSA-N 0.000 abstract 1
- 108090000312 Calcium Channels Proteins 0.000 abstract 1
- 102000003922 Calcium Channels Human genes 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001537 neural effect Effects 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702563A SE9702563D0 (sv) | 1997-07-02 | 1997-07-02 | Compounds |
| ZA985329A ZA985329B (en) | 1997-07-02 | 1998-06-18 | Compounds |
| EP98932674A EP0994859A1 (fr) | 1997-07-02 | 1998-06-22 | Composes |
| JP50700799A JP2002507988A (ja) | 1997-07-02 | 1998-06-22 | 化合物 |
| AU82498/98A AU8249898A (en) | 1997-07-02 | 1998-06-22 | Compounds |
| US09/171,172 US6057332A (en) | 1997-07-02 | 1998-06-22 | Substituted 1,4-dihydropyrimidine-5-carboxylate compounds, their preparation and uses |
| CA002294882A CA2294882A1 (fr) | 1997-07-02 | 1998-06-22 | Composes |
| PCT/SE1998/001207 WO1999001437A1 (fr) | 1997-07-02 | 1998-06-22 | Composes |
| ARP980103174A AR013152A1 (es) | 1997-07-02 | 1998-06-30 | Derivados de 2-alquilheterodihidropirimidina, proceso para su preparacion, composiciones farmaceuticas que contienen dichos derivados y el uso de dichosderivados y composiciones como ligandos para canales de calcio neuronales de tipo n. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702563A SE9702563D0 (sv) | 1997-07-02 | 1997-07-02 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9702563D0 true SE9702563D0 (sv) | 1997-07-02 |
Family
ID=20407619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9702563A SE9702563D0 (sv) | 1997-07-02 | 1997-07-02 | Compounds |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6057332A (fr) |
| EP (1) | EP0994859A1 (fr) |
| JP (1) | JP2002507988A (fr) |
| AR (1) | AR013152A1 (fr) |
| AU (1) | AU8249898A (fr) |
| CA (1) | CA2294882A1 (fr) |
| SE (1) | SE9702563D0 (fr) |
| WO (1) | WO1999001437A1 (fr) |
| ZA (1) | ZA985329B (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1193259A4 (fr) | 1999-06-23 | 2003-01-29 | Ajinomoto Kk | Derives dihydropyrimidiniques |
| JP4428053B2 (ja) | 2002-02-05 | 2010-03-10 | 味の素株式会社 | ガバペンチン若しくはプレガバリンおよびｎ型カルシウムチャンネル拮抗剤を含有する医薬組成物 |
| EP1560488B1 (fr) | 2002-11-05 | 2010-09-01 | Glaxo Group Limited | Agents antibacteriens |
| BR0317313A (pt) * | 2002-12-16 | 2005-11-08 | Astrazeneca Uk Ltd | Processo para a preparação de um composto, e, composto |
| WO2005015159A2 (fr) * | 2003-08-08 | 2005-02-17 | The Regents Of The University Of California. | Procedes de modulation d'un effet ou d'un comportement associe a un medicament |
| US10189825B2 (en) | 2012-02-08 | 2019-01-29 | Sunovion Pharmaceuticals Inc. | Heteroaryl compounds and methods of use thereof |
| KR102148678B1 (ko) | 2012-08-24 | 2020-08-27 | 선샤인 레이크 파르마 컴퍼니 리미티드 | 다이하이드로피리미딘 화합물 및 이의 약제학적 용도 |
| AU2014352404B2 (en) | 2013-11-19 | 2018-07-19 | Sunshine Lake Pharma Co., Ltd. | Dihydropyrimidine compounds and their application in pharmaceuticals |
| AU2014356986B2 (en) | 2013-11-27 | 2018-01-04 | Sunshine Lake Pharma Co., Ltd. | Processes for preparing dihydropyrimidine derivatives and intermediates thereof |
| KR20160133563A (ko) | 2014-03-28 | 2016-11-22 | 선샤인 레이크 파르마 컴퍼니 리미티드 | 다이하이드로피리미딘 화합물 및 이의 약제학적 용도 |
| TW201629054A (zh) | 2015-02-07 | 2016-08-16 | 廣東東陽光藥業有限公司 | 二氫嘧啶衍生物的複合物及其在藥物中的應用 |
| US10196403B2 (en) | 2016-07-29 | 2019-02-05 | Sunovion Pharmaceuticals Inc. | Compounds and compositions and uses thereof |
| KR20190065246A (ko) | 2016-07-29 | 2019-06-11 | 선오비온 파마슈티컬스 인코포레이티드 | 화합물 및 조성물 및 이들의 용도 |
| JP7191085B2 (ja) | 2017-08-02 | 2022-12-16 | サノビオン ファーマシューティカルズ インク | イソクロマン化合物およびその使用 |
| MX2021010880A (es) | 2019-03-14 | 2022-01-18 | Sunovion Pharmaceuticals Inc | Sales de un compuesto de isocromanilo y formas cristalinas, procesos de preparacion, usos terapeuticos y composiciones farmaceuticas de las mismas. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61271278A (ja) * | 1985-05-20 | 1986-12-01 | イ− ア−ル スクイブ アンド サンズ インコ−ポレ−テツド | ２−置換チオまたはオキソ−４−アリ−ルまたはヘテロシクロ−５−カルボキシ−１，４−ジヒドロピリミジン |
| DE69500377T2 (de) * | 1994-08-19 | 1997-10-09 | Mitsui Toatsu Chemicals | Pyrimidin-Dion-Derivate und diese enthaltende antiarrhythmische Zusammensetzungen |
-
1997
- 1997-07-02 SE SE9702563A patent/SE9702563D0/xx unknown
-
1998
- 1998-06-18 ZA ZA985329A patent/ZA985329B/xx unknown
- 1998-06-22 AU AU82498/98A patent/AU8249898A/en not_active Abandoned
- 1998-06-22 US US09/171,172 patent/US6057332A/en not_active Expired - Fee Related
- 1998-06-22 EP EP98932674A patent/EP0994859A1/fr not_active Ceased
- 1998-06-22 JP JP50700799A patent/JP2002507988A/ja active Pending
- 1998-06-22 WO PCT/SE1998/001207 patent/WO1999001437A1/fr not_active Ceased
- 1998-06-22 CA CA002294882A patent/CA2294882A1/fr not_active Abandoned
- 1998-06-30 AR ARP980103174A patent/AR013152A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2294882A1 (fr) | 1999-01-14 |
| JP2002507988A (ja) | 2002-03-12 |
| AR013152A1 (es) | 2000-12-13 |
| ZA985329B (en) | 1999-01-11 |
| US6057332A (en) | 2000-05-02 |
| EP0994859A1 (fr) | 2000-04-26 |
| WO1999001437A1 (fr) | 1999-01-14 |
| AU8249898A (en) | 1999-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9702564D0 (sv) | New compounds | |
| UA66825C2 (uk) | Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності | |
| SE9702772D0 (sv) | Novel compounds | |
| SE9702563D0 (sv) | Compounds | |
| SE9702774D0 (sv) | Novel compounds | |
| SE9701398D0 (sv) | Novel compounds | |
| AR007828A1 (es) | Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos | |
| IL133825A0 (en) | Substituted 6-phenylphenanthridines, medicaments containing same and use thereof | |
| ES2092890T3 (es) | Aplicacion del riluzol en el tratamiento de la enfermedad de parkinson y de los sindromes de parkinson. | |
| SE9703414D0 (sv) | New compounds | |
| GEP20033081B (en) | Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas | |
| SE9902765D0 (sv) | Novel compounds | |
| DE69229339D1 (de) | Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung | |
| TR200003122T2 (tr) | Aril bağlı azapolisiklik bileşikler | |
| ES2111352T3 (es) | Uso de diester fosfato para el tratamiento de enfermedades retinianas. | |
| PT861250E (pt) | Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase | |
| AR021094A1 (es) | Compuestos heterociclicos inhibidores de la fosfodiesterasa iv y su uso para el tratamiento de enfermedades inflamatorias | |
| AR024963A1 (es) | Oxazincarbazoles en el tratamiento de enfermedades del snc | |
| ES2119454T3 (es) | Derivados de pirrolidina para el tratamiento de los desordenes relacionados con la csk y la gastrina. | |
| DE59103080D1 (de) | 9-Amino-2-phenylbicyclo[3.3.1]nonane und 9-Amino-2-phenylbicyclo[3.3.1]-non-2-ene und diese enthaltende therapeutische Mittel. | |
| ES2158089T3 (es) | Uso de derivados de fosforo de alcaloides para el tratamiento de endocrinopatias. | |
| MX9705379A (es) | Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora. |